These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32464340)

  • 1. Electroconvulsive therapy decreases striatal dopamine transporter binding in patients with depression: A positron emission tomography study with [
    Masuoka T; Tateno A; Sakayori T; Tiger M; Kim W; Moriya H; Ueda S; Arakawa R; Okubo Y
    Psychiatry Res Neuroimaging; 2020 Jul; 301():111086. PubMed ID: 32464340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression.
    Moriya H; Tiger M; Tateno A; Sakayori T; Masuoka T; Kim W; Arakawa R; Okubo Y
    Psychiatry Clin Neurosci; 2020 Aug; 74(8):424-430. PubMed ID: 32363761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective
    Hellwig S; Frings L; Masuch A; Vach W; Domschke K; Normann C; Meyer PT
    J Neural Transm (Vienna); 2018 Jun; 125(6):995-1005. PubMed ID: 29476250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of dopamine transporters with [(18)F]FE-PE2I: Effects of anti-Parkinsonian drugs.
    Bang JI; Jung IS; Song YS; Park HS; Moon BS; Lee BC; Kim SE
    Nucl Med Biol; 2016 Feb; 43(2):158-64. PubMed ID: 26872440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
    Sonni I; Fazio P; Schain M; Halldin C; Svenningsson P; Farde L; Varrone A
    J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive therapy decreases dopamine D₂receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [¹¹C]FLB 457.
    Saijo T; Takano A; Suhara T; Arakawa R; Okumura M; Ichimiya T; Ito H; Okubo Y
    J Clin Psychiatry; 2010 Jun; 71(6):793-9. PubMed ID: 20021995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Tiger M; Svensson J; Liberg B; Saijo T; Schain M; Halldin C; Farde L; Lundberg J
    Psychiatry Clin Neurosci; 2020 Apr; 74(4):263-269. PubMed ID: 31943514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subanesthetic S-ketamine does not acutely alter striatal dopamine transporter binding in healthy Sprague Dawley female rats.
    Bærentzen SL; Thomsen JB; Thomsen MB; Jakobsen S; Simonsen MT; Wegener G; Brooks DJ; Landau AM
    Synapse; 2024 Jul; 78(4):e22294. PubMed ID: 38813759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal DAT changes measured with [
    Kerstens VS; Fazio P; Sundgren M; Brumberg J; Halldin C; Svenningsson P; Varrone A
    Neuroimage Clin; 2023; 37():103347. PubMed ID: 36822016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging.
    Dubol M; Trichard C; Leroy C; Granger B; Tzavara ET; Martinot JL; Artiges E
    J Affect Disord; 2020 Feb; 262():273-277. PubMed ID: 31732277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.
    Sasaki T; Ito H; Kimura Y; Arakawa R; Takano H; Seki C; Kodaka F; Fujie S; Takahata K; Nogami T; Suzuki M; Fujiwara H; Takahashi H; Nakao R; Fukumura T; Varrone A; Halldin C; Nishikawa T; Suhara T
    J Nucl Med; 2012 Jul; 53(7):1065-73. PubMed ID: 22689927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [¹⁸F]FE-PE2I.
    Kim W; Tateno A; Arakawa R; Sakayori T; Ikeda Y; Suzuki H; Okubo Y
    Int J Neuropsychopharmacol; 2014 May; 17(5):697-703. PubMed ID: 24451483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
    Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A
    Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopamine transporter availability in unmedicated bipolar disorder.
    Anand A; Barkay G; Dzemidzic M; Albrecht D; Karne H; Zheng QH; Hutchins GD; Normandin MD; Yoder KK
    Bipolar Disord; 2011 Jun; 13(4):406-13. PubMed ID: 21843280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
    Suzuki M; Ito H; Kodaka F; Takano H; Kimura Y; Fujiwara H; Sasaki T; Takahata K; Nogami T; Nagashima T; Nengaki N; Kawamura K; Zhang MR; Varrone A; Halldin C; Okubo Y; Suhara T
    Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and discriminative power of
    Delva A; Van Weehaeghe D; van Aalst J; Ceccarini J; Koole M; Baete K; Nuyts J; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter imaging with [
    Jakobson Mo S; Axelsson J; Jonasson L; Larsson A; Ögren MJ; Ögren M; Varrone A; Eriksson L; Bäckström D; Af Bjerkén S; Linder J; Riklund K
    EJNMMI Res; 2018 Nov; 8(1):100. PubMed ID: 30443684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No changes in striatal dopamine transporter in antidepressant-treated patients with major depression.
    Wu CK; Chin Chen K; See Chen P; Chiu NT; Yeh TL; Lee IH; Yang YK
    Int Clin Psychopharmacol; 2013 May; 28(3):141-4. PubMed ID: 23524636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates.
    Landau AM; Chakravarty MM; Clark CM; Zis AP; Doudet DJ
    Neuropsychopharmacology; 2011 Jan; 36(2):511-8. PubMed ID: 20944554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.